News

Hemophilia B drug available in larger vial
- Author:
- HT Staff
CSL Behring has announced that Idelvion (Coagulation Factor IX [Recombinant], Albumin Fusion Protein) is now available in a 3500 IU vial size....
News

Team identifies potential immunotherapy target for AML
- Author:
- HT Staff
New research could aid the development of immunotherapies tailored to patients with acute myeloid leukemia (AML) who are undergoing stem cell...
News

Mechanism of cGVHD response to ECP still unclear
- Author:
- HT Staff
A prospective study did not reveal the mechanism driving response to extracorporeal photopheresis (ECP) in patients with chronic graft-versus-host...
News

First CAR T-cell therapy approved in Canada
- Author:
- HT Staff
Health Canada has authorized use of tisagenlecleucel (Kymriah™), making it the first chimeric antigen receptor (CAR) T-cell therapy to receive...
News

CAR T-cell therapy will soon be available in England, NHS says
- Author:
- HT Staff
The National Health Service (NHS) of England has announced that tisagenlecleucel (Kymriah®), a chimeric antigen receptor (CAR) T-cell therapy,...
News

Humans may have more HSCs than we thought
- Author:
- HT Staff
Humans may have ten times more hematopoietic stem cells (HSCs) than previously thought, according to research published in Nature. Researchers...
News

TYK2 inhibitors could treat ALCL, team says
- Author:
- HT Staff
Preclinical research indicates that TYK2 inhibitors could be effective in treating anaplastic large-cell lymphoma (ALCL). Researchers found...
News

Research may help explain how VOCs occur
- Author:
- HT Staff
Researchers say they have gained new insight that may help explain how vaso-occlusive crises (VOCs) occur in patients with sickle cell disease (...
News

Study authors fail to disclose industry payments
- Author:
- HT Staff
New research suggests investigators involved in oncology trials sometimes fail to disclose payments from the pharmaceutical industry. Researchers...
News

Caplacizumab approved to treat aTTP
- Author:
- HT Staff
The European Commission has granted marketing authorization for caplacizumab (Cablivi™), a humanized bivalent nanobody that inhibits the...
News

Daratumumab approved for new indication in MM
- Author:
- HT Staff
The European Commission (EC) has approved a new indication for daratumumab (Darzalex®). The drug is now authorized for use in combination with...
News

Factor VIII product approved for hemophilia A
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has approved Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) for the treatment of hemophilia...
News

PLK1 inhibitor receives orphan designation for AML
- Author:
- HT Staff
The European Commission has granted orphan drug designation to onvansertib for the treatment of acute myeloid leukemia (AML). Onvansertib (...
News

A new standard of care in hemophilia A?
- Author:
- HT Staff
Results of a phase 3 trial showed that prophylaxis with emicizumab significantly reduced bleeds, compared to no prophylaxis, in patients with...
News

EC approves blinatumomab for kids
- Author:
- HT Staff
The European Commission (EC) has expanded the approved indication for blinatumomab (Blincyto®), a bispecific, CD19-directed, CD3 T-cell engager...